Fonds Vives II (University of Louvain, UCL)
Description
Fonds Vives II (University of Louvain, UCL)
Investor Profile
Fonds Vives II (University of Louvain, UCL) has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in Belgium, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (40%)
- Series A (40%)
- Seed (20%)
Country Focus
- Belgium (60%)
- United States (40%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Health Diagnostics
- Home Health Care
- Lifestyle
- Medical Device
- Wellness
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
